Abstract
The effects of six putative dopamine receptor agonists on exploratory behaviour in rats were assessed: pergolide, (+)- and (-)-3-PPP, bromocriptine, mesulergine and CQ 32-084. Behaviour was automatically recorded in a holeboard apparatus and the data were analysed by the novel multivariate statistical method of partial least squares. All six substances suppressed exploratory behaviour at low doses. Pergolide and (+)-3-PPP-induced stereotyped behaviour at higher doses. The suppression of exploration induced by pergolide was completely antagonised by sulpiride, partly antagonised by metoclopramide and weakly affected by haloperidol pretreatment. The effects of a low dose of (+)-3-PPP, bromocriptine or CQ 32-084, but not (-)-3-PPP or mesulergine, were antagonised by sulpiride. These findings support the hypotheses that pergolide, (+)-3-PPP, bromocriptine and CQ 32-084 inhibit exploration via stimulation of dopamine receptors. The present data do not substantiate the hypothesis that the suppression of exploration induced by (-)-3-PPP is mediated by stimulation of dopamine autoreceptors. A detailed analysis of the dose response curves for pergolide and (+)-3-PPP indicates that the latter compound may have effects in addition to those of a dopamine receptor agonist.
Similar content being viewed by others
References
Arnt J, Bogeso KP, Christensen AV, Hyttel J, Larsen J-J, Svendsen O (1983) Dopamine receptor agonistic and antagonistic effect of 3-PPP enantiomers. Psychopharmacology 81:199–207
Brown F, Campbell W, Mitchell PJ, Randall K (1985) Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis. Br J Pharmacol 84:853–860
Carlsson A (1975) Receptor mediated control of dopamine metabolism. In: Usdin E, Snyder S (eds) Pre- and postsynaptic receptors. Dekker, New York, pp 49–63
Clark D, Engberg G, Pileblad E, Svensson TH, Carlsson A, Freeman AS, Bunney BS (1985) An electrophysiological analysis of the action of the 3-PPP enantiomers on the nigrostriatal dopamine system. Naunyn-Schmiedebergs Arch Pharmacol 329:344–354
Corrodi H, Fuxe K, Hökfelt T, Lidbrink P, Ungerstedt U (1973) Effects of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J Pharm Pharmacol 24:409–412
Corsini GV, DelZompo M, Manconi S, Piccardi MP, Onali PL, Mangoni A, Gessa GL (1977) Evidence for dopamine receptors in the human brain mediating sedation and sleep. Life Sci 20:1613–1618
Costall B, Lim SK, Naylor RJ (1981) Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice. Eur J Pharmacol 73:175–188
Cutler NR, Jeste DV, Kaufman CA, Karoum F, Schran HF, Wyatt RJ (1984) Low dose bromocriptine: a study of acute effects in chronic medicated schizophrenics. Prog Neuropsychopharmacol Biol Psychiatr 8:277–283
Enz A (1981) Biphasic influence of a 8-alfa-aminoergoline, CU 32–085 on striatal dopamine synthesis and turnover in vivo in the rat. Life Sci 29:2227–2234
Fluckiger E, Brimer U, Burki HR, Marbach P, Wagner HR, Doepfner W (1979) Two novel prolactin release-inhibiting 8-alfa-amino-ergonlines. Experientia 35:1677–1678
Fuller RW, Clemens JA, Kornfeld EC, Snoddy HD, Smalstig EB, Bach NJ (1979) Effects of (8-beta-)-8-((methylthio)-methyl)-6-propylergoline on dopaminergic function and brain dopamine turnover in rats. Life Sci 24:375–382
Fuxe K, Corrodi H, Hökfelt T, Lidbrink P, Ungerstedt U (1974) Ergocornine and 2-Br-alfa-ergocryptine. Evidence for prolonged dopamine receptor stimulation. Med Biol 52:121–132
Fuxe K, Fredholm BB, Agnati LF, Ögren S-O, Everitt BJ, Jonsson G, Gustafsson J-Å (1978) Interaction of ergot drugs with central monoamine systems. Pharmacology 16:suppl 1, 99–134
Fuxe K, Agnati LF, Köhler C, Kuonen D, Ögren S-O, Andersson K, Hökfelt (1981) Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides. J Neural Transm 51:3–37
Herrera-Marschitz M, Hyttel J, Ungerstedt U (1984) Dopamine agonists active on D1 receptor assays induce two-peak rotation in 6-hydroxydopamine denervated rats. Abstract P-343 at 14th CINP Congress 1984
Herrera-Marschitz M, Ungerstedt U (1984) Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites. Eur J Pharmacol 98:165–176
Hjorth S (1983) On the mode of action of 3-(3-hydroxyphenyl)-N-n-propylpiperidine, 3-PPP, and its enantiomers. Acta Physiol Scand Suppl 517 (Thesis):1–58
Hjorth S, Carlsson A, Clark D, Svensson K, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-E, Johansson A, Nilsson JLG (1983) Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology 81:89–99
Jenner P, Marsden CD (1981) Substituted benzamide drugs as selective neuroleptic agents. Neuropharmacology 20:1285–1293
Lindberg W, Persson J-Å, Wold S (1983) Partial least squares method for spectrofluorimetric analysis of mixtures of humic acid and ligninsulfonate. Anal Chem 55:643–648
Ljungberg T (1978) Reliability of two activity boxes commonly used to assess drug induced behavioural changes. Pharmacol Biochem Behav 8:191–195
Ljungberg T, Ungerstedt U (1978) A method for simultaneous recording of eight behavioural parameters related to monoamine neurotransmission. Pharmacol Biochem Behav 8:483–489
Markstein R (1981) Neurochemical effects of some ergot derivatives: a basis for their antiparkinson action. J Neural Transm 51:39–59
Markstein R (1983) Mesulergine and its 1,20-N,N- bidemethylated metabolite interact directly with D1- and D2-receptors. Eur J Pharmacol 95:101–107
Meltzer HY, Kolakowska T, Robertson A, Tricou BJ (1983) Effect of low-dose bromocriptine in treatment of psychosis: the dopamine autoreceptor stimulation strategy. Psychopharmacology 81:37–41
Ögren S-O, Rodebjer A, Ängeby K (1984) The “presynaptic” blocking potency of sulpiride and haloperidol in the rat is agedependent. Neurosci Lett 46:203–207
Sibley DR, Creese I (1983) Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors. Mol Pharmacol 23:585–593
Smith RC, Tamminga CA, Davies JM (1977) Effect of apomorphine on schizophrenic symptoms. J Neural Transm 40:171–176
Ståhle L, Ungerstedt U (1984) Assessment of dopamine autoreceptor agonist properties of apomorphine, (+)-3-PPP and (-)-3-PPP by recording of yawning behaviour in rats. Eur J Pharmacol 98:307–310
Ståhle L, Ungerstedt U (1986a) Different behavioural patterns induced by the dopamine agonist apomorphine analysed by multivariate statistics. Pharmacol Biochem Behav 24:291–298
Ståhle L, Ungerstedt U (1986b) Effects of neuroleptic drugs on the inhibition of exploratory behaviour induced by apomorphine: implications for the identity of dopamine receptors. Pharmacol Biochem Behav 25:473–480
Ståhle L, Wold S (1986) On the use of multivariate statistical methods in pharmacological research. J Pharmacol Methods 16:91–110
Strömbom U (1976) Catecholamine receptor agonists: Effects on motor activity and tyrosine hydroxylation in mouse brain. Naunyn-Schmiedebergs Arch Pharmacol 292:167–176
Tossman U, Ungerstedt U (1986) The effect of apomorphine and pergolide on potassium evoked overflow of GABA in the rat striatum studied with the microdialysis technique. Eur J Pharmacol 123:295–298
Ungerstedt U, Herrera-Marschitz M, Ståhle L, Tossman U, Zetterström T (1983) Dopamine receptor mechanisms studied by correlating transmitter release and behaviour. Acta Pharm Suecica suppl 1:165–181
Wold H (1982) Soft modelling: the basic design and some extentions. In: Jöreskog KJ, Wold H (eds) Systems under indirect observation II. North Holland, Amsterdam, pp 1–54
Wold S (1978) Cross-validation of the number of factors in factor analysis and principal component analysis. Technometrics 20:397–405
Wold S, Albano C, Dunn III W.I. Esbensen K, Hellberg S, Johansson E, Sjöström M (1983) Pattern recognition: finding and using regularities in multivariate data. In: Martens H, Russworm Jr H (eds) Food research and data analysis. Applied Science Publishers, London, pp 147–188
Zetterström T (1986) Pharmacological analysis of central dopaminergic neurotransmission using a novel in vivo brain perfusion method. Thesis, Dept Pharmacology, Karolinska Institutet, Stockholm, Sweden
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ståhle, L., Ungerstedt, U. On the mode of action of six putative dopamine receptor agonists on suppression of exploratory behaviour in rats. Psychopharmacology 91, 139–146 (1987). https://doi.org/10.1007/BF00217053
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00217053